MXPA03002864A - Portafolios de pronostico de cancer de mama. - Google Patents

Portafolios de pronostico de cancer de mama.

Info

Publication number
MXPA03002864A
MXPA03002864A MXPA03002864A MXPA03002864A MXPA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A MX PA03002864 A MXPA03002864 A MX PA03002864A
Authority
MX
Mexico
Prior art keywords
breast cancer
genes
cancer prognostic
prognostic portfolio
portfolio
Prior art date
Application number
MXPA03002864A
Other languages
English (en)
Inventor
Yixin Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29215884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03002864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03002864A publication Critical patent/MXPA03002864A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un metodo para pronosticar metastasis en un paciente con cancer de mama que implica identificar modulacion diferencial de cada gen (en relacion con la expresion de los mismos genes en una poblacion normal) en una combinacion de genes seleccionados del grupo que consiste de genes; los portafolios de expresion de genes y los equipos para emplear el metodo son aspectos adicionales de la invencion.
MXPA03002864A 2002-03-29 2003-03-31 Portafolios de pronostico de cancer de mama. MXPA03002864A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36878902P 2002-03-29 2002-03-29

Publications (1)

Publication Number Publication Date
MXPA03002864A true MXPA03002864A (es) 2004-08-11

Family

ID=29215884

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002864A MXPA03002864A (es) 2002-03-29 2003-03-31 Portafolios de pronostico de cancer de mama.

Country Status (11)

Country Link
US (1) US7473526B2 (es)
EP (1) EP1367138B1 (es)
JP (1) JP2003325192A (es)
KR (1) KR20030078805A (es)
CN (1) CN1495274A (es)
AR (1) AR039213A1 (es)
AU (1) AU2003203557B2 (es)
BR (1) BR0303092A (es)
CA (1) CA2422303A1 (es)
DE (1) DE60317606T2 (es)
MX (1) MXPA03002864A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
US20050003422A1 (en) * 2003-07-01 2005-01-06 Mitch Reponi Methods for assessing and treating cancer
MXPA06009545A (es) * 2004-02-20 2007-03-07 Johnson & Johnson Pronosticos del cancer de mama.
JP2007532142A (ja) * 2004-04-23 2007-11-15 エグザジェン ダイアグノスティクス インコーポレイテッド 乳がん遺伝子発現バイオマーカー
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
CA2641410A1 (en) * 2006-02-03 2007-08-09 Messengerscape Co., Ltd. Genes for prognosis of cancer
WO2008073578A2 (en) 2006-12-08 2008-06-19 Iowa State University Research Foundation, Inc. Plant genes involved in nitrate uptake and metabolism
BRPI0913924B1 (pt) * 2008-07-01 2020-02-04 Univ Leland Stanford Junior método para determinação da probabilidade de que um indivíduo do sexo feminino irá experimentar um evento de nascimento com vida
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
US10011876B2 (en) 2010-11-23 2018-07-03 Krisani Biosciences Pvt. Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
KR101287600B1 (ko) * 2011-01-04 2013-07-18 주식회사 젠큐릭스 초기유방암의 예후 예측용 유전자 및 이를 이용한 초기유방암의 예후예측 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US635152A (en) * 1899-06-05 1899-10-17 Melancthon S Shotwell Car-body bolster.
US6350576B1 (en) * 1994-12-20 2002-02-26 Cold Spring Harbor Laboratory Cancer detection probes
EP1505159B1 (en) 1995-03-17 2008-05-28 John Wayne Cancer Institute Detection of breast metastases with a multiple marker assay
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
US6037129A (en) * 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6175624B1 (en) * 1999-03-05 2001-01-16 Centurion International, Inc. Method for connecting a battery circuit in a cellular telephone
WO2000055633A2 (en) 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Methods of screening for colorectal cancer modulators
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators
RU2251838C2 (ru) * 1999-07-15 2005-05-20 Рисерч Дивелопмент Фаундейшн Способ получения неприродной трансгенной мыши с дефицитом гена рецептора 2 кортиколиберина и ее использование
US20030235533A1 (en) * 2002-02-19 2003-12-25 Idec Pharmaceuticals Corporation Prostate specific genes and the use thereof in design or therapeutics
US20050054826A1 (en) * 2003-05-19 2005-03-10 Rosetta Inpharmatics Llc Human diaphanous-3 gene and methods of use therefor

Also Published As

Publication number Publication date
EP1367138B1 (en) 2007-11-21
US20030190656A1 (en) 2003-10-09
CN1495274A (zh) 2004-05-12
AU2003203557B2 (en) 2007-05-24
DE60317606T2 (de) 2008-10-23
AR039213A1 (es) 2005-02-09
EP1367138A3 (en) 2004-03-10
CA2422303A1 (en) 2003-09-29
AU2003203557A1 (en) 2003-10-23
US7473526B2 (en) 2009-01-06
EP1367138A2 (en) 2003-12-03
KR20030078805A (ko) 2003-10-08
DE60317606D1 (de) 2008-01-03
BR0303092A (pt) 2004-09-08
JP2003325192A (ja) 2003-11-18

Similar Documents

Publication Publication Date Title
MXPA03002862A (es) Panel de diagnostico del cancer.
MXPA03002864A (es) Portafolios de pronostico de cancer de mama.
WO2004065583A3 (en) Gene expression markers for breast cancer prognosis
WO2005100606A3 (en) Gene expression markers for predicting response to chemotherapy
WO2001094629A3 (en) Cancer gene determination and therapeutic screening using signature gene sets
AU2014899A (en) Metastatic breast and colon cancer regulated genes
WO2004085621A3 (en) Gene expression in breast cancer
EP1492440A4 (en) NEW PROCEDURE FOR THE DIAGNOSIS AND FORECAST OF MALIGNES DISEASES
MXPA04003931A (es) Pronostico de cancer de mama.
MXPA05004971A (es) Pronostico para malignidad hematologica.
WO2004101764A3 (en) Methods of modulating metastasis and skeletal related events resulting from metastases
WO2004005883A3 (en) Secreted and cytoplasmic tumor endothelial markers
DE69931759D1 (de) Methode zur erstellung von genexpressionsprofilen
MXPA03002863A (es) Valoracion de cancer colorrectal.
WO2004090547A3 (en) Metastatic colorectal cancer signatures
MXPA03002866A (es) Valoracion de cancer colorrectal.
IL126257A0 (en) Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer metastasis formation
Toncheva et al. Tissue microarray analysis of cyclin D1 gene amplification and gain in colorectal carcinomas
WO2005002414A3 (en) Prognosis determination in ewing sarcoma patients by means of genetic profiling
WO2003002765A3 (en) Methods for the diagnosis of cancer based on the obcam and ntm genes
BR0012301A (pt) Inibidores de crescimento de células epiteliais
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
WO2001062964A3 (en) A genetic determinant for malignant melanoma
AU2002348101A1 (en) Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
EP1679382A3 (en) Panel of nucleic acid sequences for cancer diagnosis

Legal Events

Date Code Title Description
FA Abandonment or withdrawal